Relay Therapeutics
Latest round
- Series C
Last raised
- Dec 2018
Total raised
- $519M
Investors
- 11
About Relay Therapeutics
Based in Massachusetts, US, and founded in 2016 by David E. Shaw, Dorothee Kern, Mark Murcko, and Matthew Jacobson, Relay Therapeutics, Inc. provides an allosteric drug-discovery platform that intends to apply computational techniques to protein motion. In 2018, Relay Therapeutics, Inc. In July 2020, Relay Therapeutics, Inc. The company is listed on Nasdaq under the ticker symbol RLAY. As of October 2021, Sanjiv K. Patel is the CEO and President of Relay Therapeutics, Inc. and employs approximately 232 people. Relay Therapeutics, Inc. provides Relay Therapeutics’ Dynamo™ platform that integrates leading computation and experimental approaches to target drug-protein that have previously been intractable. The company develops oncology therapeutics through an allosteric drug-discovery platform. It works to improve small molecule therapeutic discovery in targeted cancer, with an initial focus on improving the drug discovery process. The platform uses computational methods and experimental approaches to discover proteins' motion and function inside human cells to treat patients with cancer. Its products include RLY-1971, RLY-4008, and RLY-PI3K1047, a compound that targets cancer-associated mutant variants.2 million for the first three quarters of 2021.654 million in revenue.
Who invested in Relay Therapeutics
11 investors across 3 rounds
See all investors in Relay Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Relay Therapeutics
Who invested in Relay Therapeutics?
Relay Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Relay Therapeutics raised?
Relay Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Relay Therapeutics last raise money?
Relay Therapeutics's most recent round on record is a Series C, in Dec 2018.
What does Relay Therapeutics do?
Based in Massachusetts, US, and founded in 2016 by David E.
Where is Relay Therapeutics headquartered?
Relay Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Relay Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Relay Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Relay Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.